Select status:
Sort by:
Filter by last updated date

Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and March 2019

Filter by type
Showing 1 to 10 of 423
Title Reference number Published Last updated
Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancer Reference number:TA569 TA00569 Published:March 2019 20190301 Last updated:March 2019 20190320
Pembrolizumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (terminated appraisal) Reference number:TA570 TA00570 Published:March 2019 20190301 Last updated:March 2019 20190320
Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinib Reference number:TA571 TA00571 Published:March 2019 20190301 Last updated:March 2019 20190320
Tisagenlecleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic therapies Reference number:TA567 TA00567 Published:March 2019 20190301 Last updated:March 2019 20190313
Abatacept for treating psoriatic arthritis after DMARDs (terminated appraisal) Reference number:TA568 TA00568 Published:March 2019 20190301 Last updated:March 2019 20190313
Cochlear implants for children and adults with severe to profound deafness Reference number:TA566 TA00566 Published:March 2019 20190301 Last updated:March 2019 20190307
Benralizumab for treating severe eosinophilic asthma Reference number:TA565 TA00565 Published:March 2019 20190301 Last updated:March 2019 20190306
Venetoclax with rituximab for previously treated chronic lymphocytic leukaemia Reference number:TA561 TA00561 Published:February 2019 20190201 Last updated:February 2019 20190227
Encorafenib with binimetinib for unresectable or metastatic BRAF V600 mutation-positive melanoma Reference number:TA562 TA00562 Published:February 2019 20190201 Last updated:February 2019 20190227
Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer Reference number:TA563 TA00563 Published:February 2019 20190201 Last updated:February 2019 20190227